Stockreport

Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024

Lumos Pharma, Inc.  (LUMO) 
PDF AUSTIN, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, [Read more]